During the past decade, Yonsei Cancer Center at Yonsei University Medical Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 15 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yonsei Cancer Center at Yonsei University Medical Center" #1 sponsor was "Yonsei University" with 19 trials, followed by "Hoffmann-La Roche" with 11 trials sponsored, "Asan Medical Center" with 4 trials sponsored, "Pfizer" with 3 trials sponsored and "Cancer Therapeutics Research Group" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yonsei Cancer Center at Yonsei University Medical Center" #1 collaborator was "Breast International Group" with 3 trials as a collaborator, "Korean Cancer Study Group" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator and "Dream CIS, Inc." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Yonsei Cancer Center at Yonsei University Medical Center" are "Breast Cancer" (8 trials), "Gastric Cancer" (7 trials), "Lung Cancer" (6 trials), "Colorectal Cancer" (3 trials) and "Bladder Cancer" (2 trials). Many other conditions were trialed in "Yonsei Cancer Center at Yonsei University Medical Center" in a lesser frequency.

Most popular intervention types in "Yonsei Cancer Center at Yonsei University Medical Center" are "Drug" (50 trials), "Other" (8 trials), "Procedure" (3 trials), "Radiation" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "cisplatin" (4 trials), "tegafur-gimeracil-oteracil potassium" (4 trials), "docetaxel" (3 trials) and "gemcitabine hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Yonsei Cancer Center at Yonsei University Medical Center" are 45 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Yonsei Cancer Center at Yonsei University Medical Center". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Yonsei Cancer Center at Yonsei University Medical Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Yonsei Cancer Center at Yonsei University Medical Center, 8 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".